Evaluating the prevalence, identifying triggers, and classifying the triggers within the patients suffering from migraine

Authors

  • R Gautham Chakra Department of Pharmacy Practice, Saastra College of Pharmaceutical Education & Research, Jwalamukhi temple, Varigonda, Thotapalli Gudur mandal, near Varigonda, Nellore, Andhra Pradesh 524311 India. https://orcid.org/0009-0008-6415-1840
  • B Chandana Priya Saastra College of Pharmaceutical Education & Research, Jwalamukhi temple, Varigonda, Thotapalli gudur Mandal, near Varigonda, Nellore, Andhra Pradesh 524311 India.
  • D Bhuvaneswari Saastra College of Pharmaceutical Education & Research, Jwalamukhi temple, Varigonda, Thotapalli gudur Mandal, near Varigonda, Nellore, Andhra Pradesh 524311 India.
  • P Gowsalya Saastra College of Pharmaceutical Education & Research, Jwalamukhi temple, Varigonda, Thotapalli gudur Mandal, near Varigonda, Nellore, Andhra Pradesh 524311 India.
  • K Likhitha Saastra College of Pharmaceutical Education & Research, Jwalamukhi temple, Varigonda, Thotapalli gudur Mandal, near Varigonda, Nellore, Andhra Pradesh 524311 India.
  • K Pavan Gowtham Saastra College of Pharmaceutical Education & Research, Jwalamukhi temple, Varigonda, Thotapalli gudur Mandal, near Varigonda, Nellore, Andhra Pradesh 524311 India.

DOI:

https://doi.org/10.26452/fjphs.v5i1.704

Keywords:

Migraine, triggers, abortive treatment, prophylactic

Abstract

Migraine is a neurological condition often presenting as severe, pulsating headaches on one side of the brain. These episodes can last hours or days, significantly interfering with daily activities. This study aimed to evaluate the prevalence, identify triggers, and classify them among migraine patients. A prospective study was conducted in the Neurology Outpatient Department of KIMS Hospital, Nellore, over six months (November 2024 to May 2025). Data were collected via a specially designed questionnaire to obtain baseline information.Results: The study included 103 patients, with 82 (79.6%) females and 21 (20.4%) males. Among them, 61 (59.2%) reported migraines lasting years, 26 (25.2%) for months, and 16 (15.6%) for days. Duration of headache episodes varied, with 64 (62.1%) experiencing headaches for hours, 23 (22.3%) for minutes, and 16 (15.6%) for days. The prevalence rate was 51.5%. Patients identified various triggers, which were classified accordingly.Conclusion: The prevalence of migraines was 51.5%, highlighting a significant burden of this condition. Despite its impact, limited awareness persists. Recognizable triggers identified by patients can guide tailored treatment adjustments. This study equips primary care physicians with valuable insights to educate patients and develop effective management strategies, ultimately improving the quality of life for individuals suffering from migraines.

Downloads

Download data is not yet available.

Downloads

Published

2025-01-07

How to Cite

Chakra , R. G. ., Priya, B. C. ., Bhuvaneswari, D. ., Gowsalya, P. ., Likhitha, K. ., & Gowtham, K. P. . (2025). Evaluating the prevalence, identifying triggers, and classifying the triggers within the patients suffering from migraine. Future Journal of Pharmaceuticals and Health Sciences, 5(1), 27–35. https://doi.org/10.26452/fjphs.v5i1.704

Issue

Section

Original Articles